Search Results
-
Description Mouse MonoclonalApplications WB IHC-P IHC-Fr FCM IP Functional AssayReactivity Hu, PrimateSummary This antibody reacts with Class II epitope on CD34 (Mucosialin). This antibody has been also used as an endothelial marker.
We do not recommend use of this product for Rat,Sheep,Bovine,Dog.
$419100μg -
Description Rat MonoclonalApplications WB ICC/IF IHC-Fr FCM ELISA IHC Neutralizing /InhibitionReactivity Ms, Rat$419250μg
-
Description Mouse MonoclonalApplications IHC-Fr FCM IPReactivity Hu, Bov, Dog, Pig$419100μg
-
Description Rat MonoclonalApplications WB IHC-P IHC-Fr FCM IP ELISA Cytotoxic Assay IHC (Resin sections)Reactivity Hu, RMK$419100μg -
Description Mouse MonoclonalApplications ICC/IF IHC-Fr FCM IPReactivity Hu, Bov, PrimateSummary The mouse monoclonal antibody 104D2 detects extracellular part of CD117 / c-Kit protooncogen.
$419100μg -
Description Mouse MonoclonalApplications ICC/IF IHC-Fr FCM Cell Culture IM PurificationReactivity Ms, RatSummary Thy1.1 is a monomorphic determinant in rat but polymorphic in mice, clone MRC OX-7 reacts with Thy1.1 mice e.g. AKR and FVB, but not Thy1.2 mice such as CBA and BALB/c. The affinity of the Fab' of MRC OX-7 for rat Thy1 is 3 x 10?雋?領 and for mouse Thy1.1 is 3 x 10?置?領.
$359250μg -
Description Mouse MonoclonalApplications WB ICC/IF IHC-Fr FCM IP ELISAReactivity Hu, BovSummary This clone has been reported to bind best to the unreduced LDL-R.
$41950μg -
$419200μl
-
Description Mouse MonoclonalApplications ICC/IF IHC-P FCMReactivity Hu, Ms, Rat, PigSummary This MAb reacts with the cellular as well as plasma form of fibronectin. Reportedly, after iv administration, this MAb localizes to tumor vessels where it binds to the underlying basement. Epitope recognized by this antibody is not accessible in normal tissues to the circulating MAb indicating that it can be used to specifically target tumor vessels in vivo. TV-1 is reportedly useful for delivering vasoactive agents to tumors to induce increased vascular permeability or blood flow prior to treatment with chemotherapeutic drugs or MAbs.
$529100μg -
$429100μg